Web NewDrugInformation.com

Skin Exposure Reduction Paste Against Chemical Warfare Agents Drug - Skin Exposure Reduction Paste Against Chemical Warfare Agents The trade name of the product as shown on the labeling. Dosage - PASTE; TOPICAL The product dosage form and route separated by a semi-colon. Active Ingredient(s) - Perfluoropolymethylisopropyl Ether; Polytetrafluoroethylene Multiple ingredients are in alphabetical order. Strength - 50%;50% The potency of the active ingredient(s), Perfluoropolymethylisopropyl Ether; Polytetrafluoroethylene. May repeat for multiple part products. Applicant - US ARMY The firm name holding legal responsibility for Skin Exposure Reduction Paste Against Chemical Warfare Agents. The firm name is condensed to a maximum twenty character unique string. New Drug Application (NDA) Number - 021084 The FDA assigned number to Skin Exposure Reduction Paste Against Chemical Warfare Agents. Format is nnnnnn. Product Number - 001 The FDA assigned number to identify Skin Exposure Reduction Paste Against Chemical Warfare Agents. Each strength is a separate product. May repeat for multiple part products. Format is nnn. Therapeutic Equivalence (TE) Code - The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products. Approval Date - Feb 17, 2000 The date Skin Exposure Reduction Paste Against Chemical Warfare Agents was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982". Reference Listed Drug (RLD) - No The pioneer or innovator of Skin Exposure Reduction Paste Against Chemical Warfare Agents. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No. Type - DISCN The group or category of approved drugs Skin Exposure Reduction Paste Against Chemical Warfare Agents is in. Format is RX, OTC, DISCN. Applicant Full Name - Us Army Medical Research Materiel Command The full name of the firm holding legal responsibility for the new application of Skin Exposure Reduction Paste Against Chemical Warfare Agents. Skin Exposure Reduction Paste Against Chemical Warfare Agents Pentoxifylline 400mg Tablet, Extended Release; Oral Pentoxifylline 400mg Tablet, Extended Release; Oral Pentoxifylline 400mg Tablet, Extended Release; Oral Pentoxifylline 400mg Tablet, Extended Release; Oral Pentoxifylline 400mg Tablet, Extended Release; Oral Pentoxil 400mg Tablet, Extended Release; Oral Trental 400mg Tablet, Extended Release; Oral Imagent 100% Liquid; Oral Skin Exposure Reduction Paste Against Chemical Warfare Agents 50%;50% Paste; Topical Pentoxifylline 400mg Tablet, Extended Release; Oral NewDrugInformation